NJ A4057 | 2024-2025 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on March 11 2024 - 25% progression
Action: 2024-05-13 - Reported out of Asm. Comm. with Amendments, and Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Amended) [HTML]

Summary

Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.

Sponsors


Roll Calls

2024-05-13 - Assembly - Assembly Health Committee: Reported with Amendments (Y: 10 N: 0 NV: 1 Abs: 0) [PASS]

History

DateChamberAction
2024-05-13AssemblyReported out of Asm. Comm. with Amendments, and Referred to Assembly Financial Institutions and Insurance Committee
2024-03-11AssemblyIntroduced, Referred to Assembly Health Committee

Same As/Similar To

S3274 (Same As) 2024-05-16 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Subjects


New Jersey State Sources


Bill Comments

feedback